Literature DB >> 2867126

A role for transglutaminase in neurotransmitter release by rat brain synaptosomes.

A Pastuszko, D F Wilson, M Erecińska.   

Abstract

Rat brain synaptosomes exhibit calcium-dependent transglutaminase activity. This activity, measured in detergent-treated or sonicated preparations, was six- to sevenfold lower than that in the liver. The synaptosomal transglutaminase was inhibited by various amines and alpha-difluoromethylornithine, compounds known to inhibit activity of this enzyme in other tissues. The inhibitors of transglutaminase induced release of catecholamines, but not of gamma-aminobutyric acid, from synaptosomes both under basal and K+-stimulated conditions. The concentrations of the agents that caused stimulation of catecholamine release were approximately the same as those that inhibited the activity of transglutaminase. Stimulation of release was largely reduced by the withdrawal of calcium from the incubation medium. Inhibitors of transglutaminase had little effect either on the uptakes of neurotransmitters or the amounts of deaminated products of catecholamine degradation released into the medium. It is suggested that a synaptosomal transglutaminase is involved in suppressing vesicular release of catecholamines by resting (nondepolarized) neurons and that this action may also be a part of negative feedback control which prevents excessive transmitter release at the synapse during increased neuronal activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2867126     DOI: 10.1111/j.1471-4159.1986.tb12996.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  Transglutaminase activity in primary and subcultured rat astroglial cells.

Authors:  A Campisi; M Renis; A Russo; V Sorrenti; C Di Giacomo; C Castorina; A Vanella
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

2.  Changes in transglutaminase activity in carbon tetrachloride-damaged rat liver.

Authors:  H Kohno; K Kashimura; S Katoh; Y Ohkubo
Journal:  Experientia       Date:  1991-01-15

3.  Sensitivity of transglutaminase in rat tissues to administration of acrylamide in vivo.

Authors:  M Signorini; C M Bergamini
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

4.  In vivo inactivation of transglutaminase during the acute acrylamide toxic syndrome in the rat.

Authors:  C M Bergamini; M Signorini
Journal:  Experientia       Date:  1990-03-15

Review 5.  Transglutaminase-catalyzed protein cross-linking in the molecular program of apoptosis and its relationship to neuronal processes.

Authors:  L Fesus
Journal:  Cell Mol Neurobiol       Date:  1998-12       Impact factor: 5.046

6.  Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.

Authors:  P Kahlem; C Terré; H Green; P Djian
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.

Authors:  Maria Borrell-Pagès; Josep M Canals; Fabrice P Cordelières; J Alex Parker; José R Pineda; Ghislaine Grange; Elzbieta A Bryson; Martine Guillermier; Etienne Hirsch; Philippe Hantraye; Michael E Cheetham; Christian Néri; Jordi Alberch; Emmanuel Brouillet; Frédéric Saudou; Sandrine Humbert
Journal:  J Clin Invest       Date:  2006-04-06       Impact factor: 14.808

8.  Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length.

Authors:  A J Cooper; K R Sheu; J R Burke; O Onodera; W J Strittmatter; A D Roses; J P Blass
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

Review 9.  Transglutaminases and neurodegeneration.

Authors:  Thomas M Jeitner; John T Pinto; Boris F Krasnikov; Mark Horswill; Arthur J L Cooper
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

10.  Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.

Authors:  Anthony J Filiano; Craig D C Bailey; Janusz Tucholski; Soner Gundemir; Gail V W Johnson
Journal:  FASEB J       Date:  2008-03-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.